Document is current
Any future updates will be listed below
-
Authors
Bebell, Lisa M.
Ngonzi, Joseph
Butler, Audrey
Kumbakumba, Elias
Adong, Julian
Loos, Carolin
Boatin, Adeline A.
Bassett, Ingrid V.
Siedner, Mark J.
Williams, Paige L.
Mattie, Heather
Hedt-Gauthier, Bethany
Correia, Katharine F. B.
Lake, Erin
Alter, Galit
-
Funding
Funding for this research was provided by:
Harvard University Center for AIDS Research (P30AI060354)
Harvard Catalyst (KL2TR002542)
Charles H. Hood Foundation
National Institute of Allergy and Infectious Diseases (K23AI138856)
National Institute of Allergy and Infectious Diseases (K24AI141036)
National Institute of Allergy and Infectious Diseases (3R37AI080289-11S1)
American Society of Tropical Medicine and Hygiene (Burroughs Wellcome Postdoctoral Fellowship in Tropical Infectious Diseases)
National Institute of Allergy and Infectious Diseases,United States (R01AI146785)
Civic (CIVIC75N93019C0005)
Bill and Melinda Gates Foundation
Musk Foundation
- License Information
-
More Information
Article History
Received: 20 November 2023
Accepted: 9 May 2024
First Online: 14 May 2024
Competing interests
: GA is a V.P. at Moderna, a founder and equity holder of Seromyx Systems, and an employee and equity holder of Leyden Labs. GA’s interests were reviewed and are managed by MGH and Partners HealthCare in accordance with their conflict-of-interest policies. All other authors declare that they have no competing interests.
